Dr. Mark J. is a respected pediatrics and surgical professor at the University of Illinois College of medicine. He holds positions at the boards of various medical organizations. He is acknowledged as the co-founder of the Alliance for Advancement of Cellular Therapies (AACT) and has been serving on its executive board. Dr. Mark is the CEO as well as the Chief Medical Officer at Mariam Global Health. He has over twenty years’ experience in surgery and pediatric medicine. He has served as a pediatrics and surgery professor at the University of Illinois College of Medicine, which offer Clinical Excellence programs through their Department of Pediatrics. Read more at Vitals to know more about Dr. Mark Holterman.
Holterman, MD, has built his career as a medical researcher and an accomplished researcher for over two decades. He has received an Innovative Research Award from American Diabetes Association. Dr. Mark Holterman experience in pediatric surgery has allowed him to maintain his responsibilities as a professor of surgery and pediatrics. As an active member in his field, he supports the works of the International Pediatric Specialists Alliance for the Children of Vietnam. He graduated from medical school of the University of Virginia. Holterman is actively committed in the advancement of medicine and finding the most appropriate cure for chronic health conditions like diabetes.
As an accomplished practitioner, educator and medical researcher, Holterman knows how to split his time well in all his fields. He has dedicated most of his time to assisting patients in various ways. He has served as a member of the general surgical team at Children’s Hospital at OSF Healthcare from the year 2011. He maintains a strong interest in the development of cell-based therapies in the field of medicine. He was one of the individuals behind the establishment of a non-profit organization known as The Hannah Sunshine Foundation. He has been a co-surgeon on the first trachea transplant to be completed in a small child at OSF Saint Francis Medical Center. His focus in stem cell research is one of his significant attributions. He has been seeking essential strategies for employing ethically sourced fetal stem cells in the treatment of severe diseases. Holterman is also an active board member at TargaCell Inc., which is a biotech startup in Chicago that has created organ-specific systems for delivery of adult stem cells. Read more about his interview at ideamensch.com.